Cue Biopharma Inc (CUE)

Nov 17, 2024

Cue Biopharma Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 17, 2024

Nov 16, 2024

Cue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability - MSN

Nov 16, 2024

Nov 15, 2024

Jefferies cuts Cue Biopharma shares target, retains buy rating on potential - Investing.com UK

Nov 15, 2024

Nov 15, 2024

Cue Biopharma Inc (CUE) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role - MSN

Nov 15, 2024

Nov 14, 2024

Cue Biopharma Reports Increased Revenue Amid Ongoing Losses - TipRanks

Nov 14, 2024

Nov 14, 2024

Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Cue Biopharma Inc (CUE) Q3 2024 Earnings: EPS of $0.17 Beats Est - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times

Nov 14, 2024

Nov 14, 2024

Cue Biopharma's Cancer Drug Shows 91% Survival Rate in Phase 1 Trial, Revenue Up 57% | CUE Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Cue Biopharma Announces Strategic Organizational Transition - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Cue Biopharma Strengthens Leadership: J&J Veteran with 15+ Drug Approvals Joins as CDO | CUE Stock News - StockTitan

Nov 14, 2024

Nov 12, 2024

Cue Biopharma's SWOT analysis: stock pivot to autoimmune focus reshapes outlook - Investing.com Australia

Nov 12, 2024

Nov 12, 2024

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference - The Manila Times

Nov 12, 2024

Nov 12, 2024

Cue Biopharma to Present Latest Clinical Trial Data at Stifel Healthcare Conference | CUE Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

Cue Biopharma Presents Positive Updated Data from its Phase - GlobeNewswire

Nov 08, 2024

Nov 08, 2024

Cue Biopharma Cancer Drug Trial Soars: 91% Survival Rate, Shatters Expectations | CUE Stock News - StockTitan

Nov 08, 2024

Oct 26, 2024

Cue Biopharma, Inc. (NASDAQ:CUE) Short Interest Update - MarketBeat

Oct 26, 2024

Oct 09, 2024

Cue Biopharma authorizes more shares By Investing.com - Investing.com Australia

Oct 09, 2024

Oct 09, 2024

Cue Biopharma authorizes more shares - Investing.com India

Oct 09, 2024

Oct 09, 2024

There is no doubt that Cue Biopharma Inc (CUE) ticks all the boxes. - SETE News

Oct 09, 2024

Oct 09, 2024

Market Watch: Cue Biopharma Inc (CUE)’s Noteworthy Drop, Closing at 1.23 - The Dwinnex

Oct 09, 2024

Oct 08, 2024

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% - Yahoo Finance

Oct 08, 2024

Oct 07, 2024

Technical analysis of Cue Biopharma Inc (CUE) stock chart patterns - US Post News

Oct 07, 2024

Oct 05, 2024

Cue Biopharma stock rallies nearly 40% on upcoming presentations - MSN

Oct 05, 2024

Oct 05, 2024

Cue Biopharma amends loan agreement, easing cash requirements - Investing.com India

Oct 05, 2024

Oct 04, 2024

Cue Biopharma amends loan agreement, easing cash requirements By Investing.com - Investing.com UK

Oct 04, 2024

Oct 04, 2024

Cue Biopharma Announces Upcoming Scientific Presentations - GlobeNewswire

Oct 04, 2024

Oct 04, 2024

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting - StockTitan

Oct 04, 2024

Oct 04, 2024

Quarterly Snapshot: Quick and Current Ratios for Cue Biopharma Inc (CUE) - The Dwinnex

Oct 04, 2024

Oct 02, 2024

Biotech layoff tracker: 13 biotechs cut over 1,400 jobs - The Business Journals

Oct 02, 2024

Oct 01, 2024

Views of Wall Street’s Leading Experts on Cue Biopharma Inc - SETE News

Oct 01, 2024

Sep 30, 2024

What to expect from Cue Biopharma Inc’s (CUE) current quarter earnings? - US Post News

Sep 30, 2024

Sep 30, 2024

Cue Biopharma Inc (CUE) Stock: A Year of Highs and Lows - The InvestChronicle

Sep 30, 2024

Sep 27, 2024

Form 424B5 Cue Biopharma, Inc. - StreetInsider.com

Sep 27, 2024

Sep 27, 2024

SEC Form 424B5 filed by Cue Biopharma Inc. - Quantisnow

Sep 27, 2024

Sep 27, 2024

Wall Street SWOT: Cue Biopharma stock pivots to autoimmune focus amid restructuring - Investing.com India

Sep 27, 2024

Sep 27, 2024

Cue biopharma announces proposed public offering - MSN

Sep 27, 2024

Sep 27, 2024

Cue Biopharma prices $12M stock offering - MSN

Sep 27, 2024

Sep 27, 2024

Cue Biopharma Prices of $12.0 Million Public Offering - citybiz

Sep 27, 2024

Sep 26, 2024

Cue Biopharma Announces Pricing of $12.0 Million Public Offering - StockTitan

Sep 26, 2024

Sep 26, 2024

Cue Biopharma Announces Proposed Public Offering - The Bakersfield Californian

Sep 26, 2024

Sep 26, 2024

Cue Biopharma launches public stock offering By Investing.com - Investing.com Australia

Sep 26, 2024

Sep 26, 2024

Cue Biopharma launches public stock offering - Investing.com

Sep 26, 2024

Sep 24, 2024

Universal Music Group establishes new division in China’s Greater Bay Area, led by Gary Chan - Music Business Worldwide

Sep 24, 2024

Sep 24, 2024

Universal Music China Greater Bay Area launches to 'drive forward Chinese pop' - Music Week

Sep 24, 2024